Advertisement
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
This site complies with the HONcode standard for trustworthy health information: verify here .
Susan Hasty, Publisher Table of Contents . . . May 14th, 2003 Non-Subscriber - Summaries Only Related Areas: Other Issues in Biotech Week | Other Publications
Copernicus Therapeutics - Sustained release of DNA achieved with lipid microtubules and agarose hydrogelCordis Corp. - FDA approves drug-coated stentsBoston Scientific, Inc. - FDA approves implantGenzyme Corp. - FDA approves first treatmentNeurocrine Biosciences - Patent issued for proprietary compound for treatment of insomniaUniversity of Pittsburgh - Noninvasive glucose sensor will be worn as a contact lensAastrom Biosciences, Inc. - Collaboration agreement signed for German bone graft clinical trialAcadia Pharmaceuticals - Drug discovery alliance focused on eye care applicationsActivBiotics, Inc. - Mekalanos named to scientific advisory boardAdolor Corporation - Schied retires as chief financial officerAdvanced Magnetics, Inc. - Imaging agent maker reports net loss of $0.10 per shareAlcon, Inc., - New cataract removal system debuted; conjunctivitis drug approvedAlnylam Pharmaceuticals, Inc. - Therapeutic RNA interference company says senior management team expandedAlparslan Mah Kyzylyrmak Cad - Color Doppler imaging can quantify contraction at the tip of the LAAAlpharma, Inc. - Pharma company's senior notes due in 2011 sold in private placementAlthea Technologies, Inc. - Gene company expands to new headquarters, gets NIH contractAmerican Oriental Bioengineering - Chinese biotech company reports $1.1M profitAntares Pharma, Inc. - Trial of needle-free drug delivery system beginsAnthem, Inc. - Pharmaceutical company raises 2003 outlookArQule, Inc. - Biotech company reports net loss of $0.03 per shareBarr Laboratories, Inc. - Approval granted for generic AccutaneBaxter International, Inc. - Sales grew 6% while earnings declined for pharma companyBioSeek, Inc. - Sigal added to scientific advisory boardBiogen, Inc. - Revenues increase 11% in first quarter for biotech companyBiomerica, Inc. - Net loss reported at $0.00 for biotech companyBiosyntrx - Ophthalmic company announces new board member, start of new trialBristol-Myers Squibb Company - FDA approves Glucophage XR 750 mg tabletsCV Therapeutics, Inc. - Net loss of $0.75 per share reported by drug development companyCanji Inc. - Multiple cycles of p53 gene therapy may inhibit recurrent ovarian tumorsCelgene Corporation - Fast track status granted for Revimid; agreement signed for AlkeranCellomics, Inc. - Extended Neurite Outgrowth BioApplication releasedCelltech Group plc - New CEO named at U.K. biotech companyCellular Genomics, Inc. - Industry consultant named to key drug development positionChiron Corporation - Phase III trial for meningococcal C vaccine beginsConnetics Corporation - Capello, Hirsch named VPs at dermatology companyCryo-Cell International - 50,000th Cord blood specimen processedCryo-Cell International, Inc. - Interim CEO, president named to lead strategic transformationCryoCath Technologies - Position in strategic surgical ablation market fortified with allianceCutting Edge Information - Analysis says pharma companies must increase local "thought leader" useCutting Edge Information - Pharmaceutical sales reps adapt to new HIPAA guidelinesDanish Cancer Society - The sex ratio among offspring of childhood cancer survivors is unalteredDeltagen, Inc. - Revenue increases 93% for drug discovery companyDynPort Vaccine Co. - Phase I smallpox vaccine clinical trial completedElite Pharmaceuticals - Opioid antagonist product developed for abuse resistanceElite Pharmaceuticals, Inc. - Controlled release product completes phase I bioavailability studyEndocardial Solutions, Inc. - Nigon, Peltier named as directorsEnglyst Carbohydrates Research and Service Ltd. - Glycemic index of cereal products explained by available glucoseEntropin, Inc. - ENT-103 receives positive review from panel of pain expertsFluor Corp. - Large cell culture manufacturing facility to be built in DenmarkFresenius Medical Care - New FX dialyzer proves highly effectiveGalen Holdings PLC - Women's healthcare products portfolio acquired from PfizerGenVec, Inc. - Newly combined company to commercialize cancer, heart disease drugsGeneMax Corp - Director clarifies SEC action, company positionGenmab A/S - Management change announced at biotech company following CFO's resignationGenset Corp. - Gene variation raises riskGenter Inc. - Zinc expands the feasibility of using exocrine glands for gene transferGenzyme Corp. - First quarter yields 30% increase in revenuesGlaxoSmithKline - Discovery of HM74A, target for nicotinic acid, may lead to discovery of drugGlaxoSmithKline - Investor ask pharma company to lower AIDS drug pricesGlaxoSmithKline - Lamotrigine found effective for maintenance treatment of bipolar I disorderGlaxoSmithKline - Prescription drug settlement announced in Medicaid fraud casesHoffmann-La Roche - AIDS groups to pressure big pharma to lower cost of FuzeonI-trax, Inc. - Disease management company reports more than 500% revenue growthIconix Pharmaceuticals - Chemogenomic profiling relationship initiatedImmunomedics, Inc. - Additional patent granted for proprietary treatment of infectious diseaseImmusol - VIT100 enters phase I studyInex Pharmaceuticals - IND filed for topotecan encapsulated in transmembrane carrier systemIngenium Pharmaceuticals AG - INGENOtyping agreement signedIntegrated Health Technologies, Inc. - Name change becomes effective; shares to be listed on AMEXIntrogen Therapeutics - Independent review of anticancer drugs reports initial clinical successesIntrogen Therapeutics, Inc. - INGN 241 combined with radiation shows promise during preclinical testingIntrogen Therapeutics, Inc. - Preclinical drug studies accelerate understanding of MDA-7 gene functionsIsolagen, Inc. - Regulatory approval sought for biologic to repair scars
Janssen Pharmaceutica - Antipsychotic drug risperidone reduces tics in children and adultsJohnson & Johnson - First quarter EPS rose 16.9% on sales increase of 12.3% for pharmaceutical giantJuvaris BioTherapeutics, Inc. - Warner named chief scientific officerKH Barmherzige Bruder - Imaging can help diagnose acute left lower quadrant painKensey Nash Corporation - Biomaterials maker reports 99% increase in net incomeKing Pharmaceuticals - Pharmaceutical company produces documentation for SECLynx Therapeutics, Inc. - Technique produces comprehensive view of transcriptomesMasimo Corp. - Study compares pulse oximeters in congenital heart defect patientsMcNeil Consumer & Specialty Pharmaceuticals - Muscle relaxer Flexeril reaches pharmaciesMedMira Inc. - FDA approves rapid, point-of-care test to detect HIV-1 antibodiesMedamicus, Inc. - Medical products company releases first quarter resultsMedarex, Inc. - Partnership aims to develop fully human therapeutic antibodiesMedical Services International Inc. - Agreement signed to distribute HIV test kit in The CongoMedline Industries, Inc. - First controlled-release, antimicrobial silver hydrogel now available in U.S.Merck Research Laboratories - Integracide A exhibits inhibitory activity against HIV-1 integraseMillennium Pharmaceuticals - Company's first quarter 2003 results impacted by heart and cancer drugsMillennium Pharmaceuticals - Research identifies molecular pathway related to infection-fighting mechanismMojave Therapeutics - Clinical results reported for heat shock protein-based immunotherapyMolecular Engines Laboratories - Study suggests company's gene product could play role in tumor reversionMoore Medical Corp. - Medical products distributor adds executivesNabi Biopharmaceuticals - S. aureus whole cell vaccine technology licensed for use in cowsNastech Pharmaceutical - Development and commercialization rights for intranasal apomorphine reacquiredNeoPharm, Inc. - New preclinical data released for novel liposomal drug formulationsNeothermia Corp. - Cancer diagnostics firm completes venture-backed financing roundNeurome, Inc. - First 3D reconstruction developed of mouse model of AD pathologyNovarex GmbH - New women's condom available at 20,000 German pharmaciesOntogen Corporation - Pyrrolopyrazinedione-based inhibitors of hormone-sensitive lipase discoveredOulu University Hospital - Infliximab may reduce sciatica painOxxon Pharmaccines Ltd. - Therapeutic vaccines firm raises UKP15 million in international funding roundPPD, Inc. - Equity investment supports research on blood recovery therapeutic peptideParadigm Genetics - Biotech company boosts human health unitParexel International Corp. - Outsourcing group buys interest in Asia-Pacific-based contract research companyPfizer Inc. - Diflucan partnership program launched in ZimbabwePfizer Inc. - Patient assistance programs expanded, drug giant announcesPfizer Inc. - World's largest, research-based, pharmaceutical company createdPfizer, Inc. - FTC clears acquisition plans for pharma giantsPharmacia - Report: Pfizer to conduct 'mass layoffs' after takeoverPlanmed Inc. - Breakthrough in mammographic technology announcedPolish Academy Science - Diagnosis of cerebral ischemia in less than 1% of patients did not prove harmfulPossis Medical, Inc. - Clinical study underway for innovative blood-clot removal systemPrana Biotechnology Ltd. - Discovery of beta-amyloid in eyes of AD patients may aid diagnosticsPrecis Therapeutics, Inc. - An in vitro assay can be used as a surrogate for clinical therapeutic challengePrimal, Inc. - Family of G-protein coupled receptor genes definedQuark Biotech, Inc. - Unique method developed for function-based identification of genesRicerca Biosciences, LLC - Biosciences company announces management changeRoche Diagnostics Corp. - Corporation announces major expansion plans for North American headquartersSirna Therapeutics - Company's new focus prompts name changeSleep Solutions, Inc. - Sleep disorders testing firm names new president, directorSmith Micro Software, Inc. - Company to provide video capabilities to new joint ventureSontra Medical Corp. - Initial clinical results on non-invasive continuous monitoring product reportedSt. Jude Children's Research Hospital - St. Jude to manufacture investigative drugs and vaccinesSunTech Medical Instruments - Blood pressure monitoring specialist announces medical advisory board expansionSunTech Medical Instruments - Revolutionary cuff design unveiledTechnical Insights - Membrane separation technology has applications in many industriesTheratechnologies - First quarter 2003 results released by biotech firmTm Bioscience Corp. - Company enlists clinical laboratories for early access programTransgene - Recent review of DNA vaccines publishedUnited Therapeutics Corp. - Long-term therapy with treprostinil improves survivalUniversity of Alberta - Automated quantitative analysis of chest phantom radiographs is developedUniversity of Colorado - Dual acceptance window technique reduces respiratory motion artifactsUniversity of Oslo - Electron microscopy is a useful tool for differential diagnosisV.I. Technologies, Inc. - U.S. patent coverage expanded for pathogen inactivation in red blood cellsValentis, Inc. - Company receives NASDAQ panel decisionVantageMed Corp. - Healthcare information firm announces change in senior managementVascular Solutions, Inc. - Hematologic device company reports first quarter 2003 resultsVasogen, Inc. - Fuster joins scientific advisory board at immune modulation companyViroLogic, Inc. - Phenotypic drug susceptibility data correlate with improved long-term outcomesWatson Pharmaceuticals, Inc. - Web site available for oral contraceptive informationWomen's Capitol Corp. - Company asks to sell morning-after pill without prescriptionWyeth Pharmaceuticals - FDA approves new indication for RapamuneXenova Group plc - Patient dosing begins in Phase IIa trial for anticocaine addiction vaccineXenova Group plc - Phase II study results of vaccine combination releasedZapaq Inc. - Fundamental U.S. patent on tools for discovering memapsin 2 inhibitorsZapaq, Inc. - OMRF gets patent for company researching treatmentaaiPharma Inc. - Acquisition of injectable treatment for severe pain announced
Return to Top of Page
